Souleymane Tassembedo,Nicolas Meda,Chipepo Kankasa,Roger Shapiro,Theodore Ruel,Ameena Goga,Mwiya Mwiya,Isidore Tiandiogo Traore,Thorkild Tylleskär,Anais Mennecier,Jean Pierre Moles,Philippe Van de Perre,Nicolas Nagot
{"title":"撒哈拉以南非洲儿童的艾滋病毒预防和未确诊感染。","authors":"Souleymane Tassembedo,Nicolas Meda,Chipepo Kankasa,Roger Shapiro,Theodore Ruel,Ameena Goga,Mwiya Mwiya,Isidore Tiandiogo Traore,Thorkild Tylleskär,Anais Mennecier,Jean Pierre Moles,Philippe Van de Perre,Nicolas Nagot","doi":"10.1016/s2352-3018(25)00070-0","DOIUrl":null,"url":null,"abstract":"Despite the efforts to prevent vertical transmission of HIV, about 130 000 children worldwide acquire HIV each year, and 40% of those remain undiagnosed. Many factors contribute to this poor outcome including, but not limited to, failure to identify mothers seroconverting during pregnancy or postpartum, suboptimal early infant diagnosis, misinterpretation of negative test results in children before the end of breastfeeding, and child testing not being a key indicator for national programmes. To close the paediatric HIV diagnosis gap and improve child mortality rates, several changes are necessary. These changes include intensifying HIV retesting efforts to identify women who seroconvert during pregnancy or breastfeeding, counselling caregivers and health-care providers on the necessity of doing a final HIV test in children after breastfeeding ends, setting a formal indicator for child testing between age 18 months and 24 months, and extending child HIV diagnosis as a concern for all health-care workers when the children leave the programme to prevent vertical transmission of HIV after 2 years.","PeriodicalId":48725,"journal":{"name":"Lancet Hiv","volume":"9 1","pages":""},"PeriodicalIF":12.8000,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"HIV prevention and undiagnosed infections in children in sub-Saharan Africa.\",\"authors\":\"Souleymane Tassembedo,Nicolas Meda,Chipepo Kankasa,Roger Shapiro,Theodore Ruel,Ameena Goga,Mwiya Mwiya,Isidore Tiandiogo Traore,Thorkild Tylleskär,Anais Mennecier,Jean Pierre Moles,Philippe Van de Perre,Nicolas Nagot\",\"doi\":\"10.1016/s2352-3018(25)00070-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Despite the efforts to prevent vertical transmission of HIV, about 130 000 children worldwide acquire HIV each year, and 40% of those remain undiagnosed. Many factors contribute to this poor outcome including, but not limited to, failure to identify mothers seroconverting during pregnancy or postpartum, suboptimal early infant diagnosis, misinterpretation of negative test results in children before the end of breastfeeding, and child testing not being a key indicator for national programmes. To close the paediatric HIV diagnosis gap and improve child mortality rates, several changes are necessary. These changes include intensifying HIV retesting efforts to identify women who seroconvert during pregnancy or breastfeeding, counselling caregivers and health-care providers on the necessity of doing a final HIV test in children after breastfeeding ends, setting a formal indicator for child testing between age 18 months and 24 months, and extending child HIV diagnosis as a concern for all health-care workers when the children leave the programme to prevent vertical transmission of HIV after 2 years.\",\"PeriodicalId\":48725,\"journal\":{\"name\":\"Lancet Hiv\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":12.8000,\"publicationDate\":\"2025-04-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lancet Hiv\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/s2352-3018(25)00070-0\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Hiv","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s2352-3018(25)00070-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
HIV prevention and undiagnosed infections in children in sub-Saharan Africa.
Despite the efforts to prevent vertical transmission of HIV, about 130 000 children worldwide acquire HIV each year, and 40% of those remain undiagnosed. Many factors contribute to this poor outcome including, but not limited to, failure to identify mothers seroconverting during pregnancy or postpartum, suboptimal early infant diagnosis, misinterpretation of negative test results in children before the end of breastfeeding, and child testing not being a key indicator for national programmes. To close the paediatric HIV diagnosis gap and improve child mortality rates, several changes are necessary. These changes include intensifying HIV retesting efforts to identify women who seroconvert during pregnancy or breastfeeding, counselling caregivers and health-care providers on the necessity of doing a final HIV test in children after breastfeeding ends, setting a formal indicator for child testing between age 18 months and 24 months, and extending child HIV diagnosis as a concern for all health-care workers when the children leave the programme to prevent vertical transmission of HIV after 2 years.
期刊介绍:
The Lancet HIV is an internationally trusted source of clinical, public health, and global health knowledge with an Impact Factor of 16.1. It is dedicated to publishing original research, evidence-based reviews, and insightful features that advocate for change in or illuminates HIV clinical practice. The journal aims to provide a holistic view of the pandemic, covering clinical, epidemiological, and operational disciplines. It publishes content on innovative treatments and the biological research behind them, novel methods of service delivery, and new approaches to confronting HIV/AIDS worldwide. The Lancet HIV publishes various types of content including articles, reviews, comments, correspondences, and viewpoints. It also publishes series that aim to shape and drive positive change in clinical practice and health policy in areas of need in HIV. The journal is indexed by several abstracting and indexing services, including Crossref, Embase, Essential Science Indicators, MEDLINE, PubMed, SCIE and Scopus.